SCHEMBL2330407

SCHEMBL2330407

CCCC(=O)c1cccc(C(=O)N[C@@H](CS(=O)(=O)O)C(=O)O)c1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.39
CTSS P25774 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38
APEX1 P27695 4/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
ITGB1 P05556 1/20 0.34
ITGA4 P13612 1/20 0.34
ITGB7 P26010 1/20 0.34
C3AR1 Q16581 1/20 0.34
CA2 P00918 1/20 0.34
TACR3 P29371 2/20 0.34
NR1H4 Q96RI1 1/20 0.34
TACR2 P21452 1/20 0.34
CYP1A1 P04798 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2330372 0.93 USP2 (0.38) USP2CTSSTAS1R3TAS1R1APEX1
SCHEMBL2333701 0.90 TAS1R3 (0.40) USP2CTSSTAS1R3TAS1R1APEX1
SCHEMBL2324220 0.87 USP2 (0.42) USP2CTSSAPEX1MEN1KMT2A
SCHEMBL2331119 0.86 HPGD (0.39) MEN1KMT2AFNTAFNTBITGB1
SCHEMBL2331128 0.86 HPGD (0.39) MEN1KMT2AFNTAFNTBITGB1
SCHEMBL2324780 0.84 USP2 (0.43) USP2CTSSTAS1R3TAS1R1APEX1
SCHEMBL2329702 0.82 TAS1R3 (0.40) USP2CTSSTAS1R3TAS1R1APEX1
SCHEMBL2328097 0.81 FNTA (0.49) USP2KMT2AFNTAFNTBCA2
SCHEMBL2334197 0.77 HPGD (0.56) USP2KMT2ANPC1RAB9A
SCHEMBL2334202 0.77 HPGD (0.56) USP2KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2356979-B1 ANTI-WRINKLE AGENTS POLA CHEM IND INC (JP) 2017-10-25 EP disclosed
EP-3173063-A1 ANTI-WRINKLE AGENTS Pola Chemical Industries Inc. (JP) 2017-05-31 EP disclosed
US-8835498-B2 Anti-wrinkle agents POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-16 US disclosed
US-20110245343-A1 ANTI-WRINKLE AGENTS POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed
EP-2356979-A1 ANTI-WRINKLE AGENTS Pola Chemical Industries Inc. (JP) 2011-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245343-A1 ANTI-WRINKLE AGENTS GLA, H1-4, H1-3 USP2 2398/4885CTSS 2035/4885TAS1R3 746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.